Target type: biologicalprocess
The chemical reactions and pathways resulting in the breakdown of glucuronosides, compound composed of a hydroxy compound linked to a glucuronate residue. [ISBN:0198506732]
Glucuronoside catabolic process involves the breakdown of glucuronides, which are compounds formed by attaching glucuronic acid to various molecules, including steroids, bilirubin, hormones, and drugs. This process is crucial for detoxification, elimination of waste products, and maintaining homeostasis.
The primary enzyme responsible for glucuronide catabolism is glucuronidase. This enzyme hydrolyzes the glucuronide bond, releasing glucuronic acid and the original molecule.
The process begins in the liver, where glucuronidation, the addition of glucuronic acid, occurs. This conjugation process increases the water solubility of the target molecule, facilitating its excretion in urine or bile.
Once in the intestines, bacterial enzymes, particularly beta-glucuronidase, can cleave the glucuronide bond, releasing the original molecule and glucuronic acid. This process can lead to the reabsorption of the original molecule, potentially affecting its activity or increasing its toxicity.
Glucuronoside catabolism is essential for maintaining homeostasis by:
* **Detoxification:** Glucuronidation of toxic compounds, such as bilirubin, promotes their excretion.
* **Elimination of waste products:** Glucuronides facilitate the removal of waste products, such as steroid hormones and drugs.
* **Hormonal regulation:** Glucuronidation of hormones can regulate their activity and prevent their accumulation.
* **Drug metabolism:** Glucuronidation plays a crucial role in the metabolism and elimination of drugs, influencing their efficacy and duration of action.
Dysregulation of glucuronoside catabolism can lead to various health problems, including:
* **Jaundice:** Impaired glucuronidation of bilirubin can cause its accumulation, leading to jaundice.
* **Drug toxicity:** Increased reabsorption of drugs due to altered glucuronide catabolism can enhance their toxicity.
* **Hormonal imbalances:** Dysregulation of glucuronide catabolism can disrupt hormonal balance, leading to various physiological effects.
Therefore, understanding the complexities of glucuronoside catabolism is essential for developing strategies to address health issues associated with its dysregulation.'
"
Protein | Definition | Taxonomy |
---|---|---|
Beta-glucuronidase | A beta-glucuronidase that is encoded in the genome of Escherichia coli K-12. [OMA:P05804, PRO:DNx] | Escherichia coli K-12 |
Beta-glucuronidase | A beta-glucuronidase that is encoded in the genome of Escherichia coli K-12. [OMA:P05804, PRO:DNx] | Escherichia coli K-12 |
Beta-glucuronidase | A beta-glucuronidase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P08236] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
dehydroepiandrosterone | dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands. Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion. | 17-oxo steroid; 3beta-hydroxy-Delta(5)-steroid; androstanoid | androgen; human metabolite; mouse metabolite |
androstenedione | androst-4-ene-3,17-dione : A 3-oxo Delta(4)-steroid that is androst-4-ene substituted by oxo groups at positions 3 and 17. It is a steroid hormone synthesized in the adrenal glands and gonads. Androstenedione: A delta-4 C19 steroid that is produced not only in the TESTIS, but also in the OVARY and the ADRENAL CORTEX. Depending on the tissue type, androstenedione can serve as a precursor to TESTOSTERONE as well as ESTRONE and ESTRADIOL. | 17-oxo steroid; 3-oxo-Delta(4) steroid; androstanoid | androgen; Daphnia magna metabolite; human metabolite; mouse metabolite |
glycyrrhetinic acid | cyclic terpene ketone; hydroxy monocarboxylic acid; pentacyclic triterpenoid | immunomodulator; plant metabolite | |
glycyrrhizic acid | glycyrrhizinic acid : A triterpenoid saponin that is the glucosiduronide derivative of 3beta-hydroxy-11-oxoolean-12-en-30-oic acid. | enone; glucosiduronic acid; pentacyclic triterpenoid; tricarboxylic acid; triterpenoid saponin | EC 3.4.21.5 (thrombin) inhibitor; plant metabolite |
methyl methanethiosulfinate | methyl methanethiosulfinate: structure in first source; a metabolite of S-methyl cysteine sulfoxide | sulfur oxoacid derivative | |
saccharolactone | D-glucaro-1,4-lactone : A delta-lactone that is D-glucono-1,4-lactone in which the hydroxy group at position 6 has been oxidised to the corresponding carboxylic acid. saccharolactone: used as index for assessing induction of hepatic enzymes by anticonvulsants; RN given refers to cpd without isomeric designation | aldarolactone; delta-lactone | |
2,2'-dihydroxychalcone | 2,2'-dihydroxychalcone: an antineoplastic agent; structure in first source | ||
1-[4-[(2-methyl-4-quinolinyl)amino]phenyl]ethanone | aromatic ketone | ||
kaempferol | 7-hydroxyflavonol; flavonols; tetrahydroxyflavone | antibacterial agent; geroprotector; human blood serum metabolite; human urinary metabolite; human xenobiotic metabolite; plant metabolite | |
mangiferin | shamimin: isolated from the leaves of Bombax ceiba; structure in first source | C-glycosyl compound; xanthones | anti-inflammatory agent; antioxidant; hypoglycemic agent; plant metabolite |
kuwanon g | kuwanon G: a non-peptide bombesin receptor antagonist; RN refers to (1S-(1alpha,5alpha,6beta))-isomer; structure given in first source kuwanone G : A tetrahydroxyflavone isolated from the root barks of Morus alba and has been shown to exhibit anti-inflammatory activity. | resorcinols; tetrahydroxyflavone | anti-inflammatory agent; plant metabolite |
2',5'-dihydroxychalcone | 2',5'-dihydroxychalcone: structure given in first source | chalcones | |
ginkgolide b | |||
b355252 | |||
2-(4-methoxyphenyl)-1H-quinazolin-4-one | quinazolines |